NovaBay Pharmaceuticals Inc (NBY) — Capital Reinvestment Ratio
NovaBay Pharmaceuticals Inc (NBY) has a Capital Reinvestment Ratio of 0.26x as of September 2017, meaning it reinvests 0% of its operating cash flow ($281.00K) in capital expenditures ($73.00K). See debt-free asset ratio of NovaBay Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NovaBay Pharmaceuticals Inc Capital Reinvestment Ratio (2006–2010)
This chart tracks NovaBay Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Check how aggressively does NovaBay Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for NovaBay Pharmaceuticals Inc (2006–2010)
Year-by-year Capital Reinvestment Ratio for NovaBay Pharmaceuticals Inc from 2006 to 2010. For live market cap and broader valuation context, see NovaBay Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.10x | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $4.74 Million | $362.00K | — |